Subject: Smallcap Discoveries: ImmunoPrecise Antibodies (NASDAQ: IPA) Update with CEO Jennifer Bath

ImmunoPrecise Antibodies (NASDAQ: IPA) Update with CEO Jennifer Bath
About ImmunoPrecise Antibodies Ltd.

ImmunoPrecise Antibodies Ltd. is a biotherapeutic research and technology company that leverages systems biology, multi-omics modelling and complex artificial intelligence systems to support its proprietary technologies in bioplatform-based antibody discovery. Services include highly specialized, full-continuum therapeutic biologics discovery, development, and out-licensing to support its business partners in their quest to discover and develop novel biologics against the most challenging targets. For further information, visit www.ipatherapeutics.com.

Video Interview:
After our interviews, we host a Free-For-All session with the live participants to review all things Smallcap Discoveries is following, including updates and commentary companies from both the Select Portfolio and Select Watchlist
[[internal_footer]]